ABS0935 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL TO EVALUATE THE PRELIMINARY EFFICACY, SAFETY OF REPEATED ADMINISTRATION OF XELIGEKIMAB (GR1501) INJECTION IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS
Dong Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Norella Kong(Huashan Hospital), Yuzhou Zhao(Capital Medical University), Xiaofeng Zeng(Ministry of Education of the People's Republic of China), Li Sun(Xuzhou Central Hospital), Huan Liu(West China Hospital of Sichuan University), Xiaolin Li(Guangzhou University of Chinese Medicine), Jing Hu(Zhujiang Hospital), Xiaowen Fan(Bengbu Medical College), Yan Xue(Huashan Hospital), S. Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zefei Jiang(Jilin University), L. Shen(ENN (China))
Cited by 1
Related Papers
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
|Journal of the American Society of Nephrology|2004|2k
The classification of glomerulonephritis in systemic lupus erythematosus revisited
|Kidney International|2004|1.7k
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
|Arthritis & Rheumatism|2010|481
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374
Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
|Journal of Experimental & Clinical Cancer Research|2019|324